Literature DB >> 23430468

Preventing expression of the nicotinic receptor subunit α7 in SH-SY5Y cells with interference RNA indicates that this receptor may protect against the neurotoxicity of Aβ.

Xiao-Lan Qi1, Kai Ou-Yang, Jia-Mou Ren, Chang-Xue Wu, Yan Xiao, Yi Li, Zhi-Zhong Guan.   

Abstract

The present aim was to characterize the influence of the α7 nicotinic acetylcholine receptor (nAChR) on BACE, the enzyme that cleaves the amyloid precursor protein (APP) at the β-site, as well as on the oxidative stress induced by amyloid-β peptide (Aβ). To this end, human neuroblastoma SH-SY5Y cells were transfected with siRNAs targeting the α7 nAChR subunit and/or exposed to Aβ1-42. For α7 nAChR, BACE1 (cleaving at the β-site of APP) and BACE2 (cleaving within the Aβ domain), α-secretase (ADAM10), and the two components of γ-secretase, PS and NCT, the mRNA and protein levels were determined by real-time PCR and Western blotting, respectively. The level of Aβ1-42 in the cell culture medium was determined by an ELISA procedure. The extent of lipid peroxidation and activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were assayed spectrophotometrically. In the transfected SH-SY5Y cells, expression of α7 nAChR was reduced; the level of BACE1 increased and that of BACE2 decreased; the amount of ADAM10 lowered; and the level of PS raised. Moreover, the level of Aβ1-42 in the culture medium was elevated. Treatment of non-transfected cells with Aβ elevated the level of malondialdehyde (MDA) and lowered the activities of SOD and GSH-Px and these changes were potentiated by inhibiting expression of α7 nAChR. These results indicate that α7 nAChR plays a significant role in amyloidogenic metabolism of APP and the oxidative stress evoked by Aβ, suggesting that this receptor might help protect against the neurotoxicity of Aβ.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430468     DOI: 10.1007/s11064-013-1001-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.

Authors:  Xiao-Lan Qi; Agneta Nordberg; Jin Xiu; Zhi-Zhong Guan
Journal:  Neurochem Int       Date:  2007-04-08       Impact factor: 3.921

3.  beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

Authors:  D L Pettit; Z Shao; J L Yakel
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 4.  Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.

Authors:  A Nordberg
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

5.  Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype.

Authors:  Angelo O Rosa; Javier Egea; Luís Gandía; Manuela G López; Antonio G García
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 6.  Amyloid oligomers: formation and toxicity of Abeta oligomers.

Authors:  Masafumi Sakono; Tamotsu Zako
Journal:  FEBS J       Date:  2010-02-09       Impact factor: 5.542

7.  Activation of α7 nicotinic receptor affects APP processing by regulating secretase activity in SH-EP1-α7 nAChR-hAPP695 cells.

Authors:  Hui Zhen Nie; Sha Shi; Ronald J Lukas; Wen Juan Zhao; Yong Ning Sun; Ming Yin
Journal:  Brain Res       Date:  2010-08-12       Impact factor: 3.252

Review 8.  Neuronal nicotinic receptors in the human brain.

Authors:  D Paterson; A Nordberg
Journal:  Prog Neurobiol       Date:  2000-05       Impact factor: 11.685

9.  Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease.

Authors:  Kazuma Murakami; Takahiko Shimizu; Kazuhiro Irie
Journal:  J Amino Acids       Date:  2011-01-16

10.  An update on the toxicity of Abeta in Alzheimer's disease.

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock; Roberto Cappai
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more
  2 in total

1.  Original Research: Influence of okadaic acid on hyperphosphorylation of tau and nicotinic acetylcholine receptors in primary neurons.

Authors:  Liang Zhao; Yan Xiao; Xiao-Liang Wang; Jinjing Pei; Zhi-Zhong Guan
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-13

2.  Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.

Authors:  Xiao-Ling Wang; Yu-Xin Deng; Yu-Mei Gao; Yang-Ting Dong; Fan Wang; Zhi-Zhong Guan; Wei Hong; Xiao-Lan Qi
Journal:  Aging (Albany NY)       Date:  2020-01-06       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.